Ma. Lockett et al., DETECTION OF OCCULT BREAST-CANCER MICROMETASTASES IN AXILLARY LYMPH-NODES USING A MULTIMARKER REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION PANEL, Journal of the American College of Surgeons, 187(1), 1998, pp. 9-16
Background: Axillary lymph node status in breast cancer patients remai
ns the single most important predictor of outcomes. Current methods of
histopathologic analysis may be inadequate because 30% of node-negati
ve patients recur. The purpose of this study was to test the hypothesi
s that a multigene reverse transcriptase-polymerase chain reaction (RT
-PCR) panel provides a more sensitive method to detect axillary lymph
node metastases than routine pathologic examination. Study Design: Six
ty-one consecutive breast cancer patients were evaluated, with nine no
rmal control patients. Nodes > 1 cm were bisected for histopathologic
and RT-PCR analysis. Nodal tissue was homogenized, and total RNA was c
onverted into cDNA with reverse transcriptase. Reverse transcriptase-p
olymerase chain reaction analysis was performed with primers specific
for keratin-19, c-myc, prolactin inducible protein (PIP), and beta-act
in using ethidium bromide gel electrophoresis. Reverse transcriptase-p
olymerase chain reaction positive/ pathology negative axillary lymph n
odes were reevaluated using step sectioning and immunohistochemical st
aining. Results: Thirty-seven patients had pathologically negative axi
llary lymph nodes, of which 15 (40%) were positive by RT-PCR analysis.
Two RT-PCR negative results tone probably from tissue processing erro
r and the other secondary to sampling error) among the 24 histological
ly positive specimens were detected (8%). The number of patients in ea
ch pathologic stage was 26 patients in stage I; 18, stage IIA; 7, stag
e IIB; 7, stage IIIA; 3, stage IIIB; and 0 patients in stage TV. By RT
-PCR staging, 8 of 26 patients went from stage I to IIA (30%), and 7 o
f 18 from stage IIA to IIB (39%). Of the RT-PCR positive individuals w
ho were stage I by pathologic analysis, 100% were found to be c-myc po
sitive, 0% keratin-19 positive, and 0% PIP positive; for stage IIIB pa
tients these markers were 50%, 100%, and 100% respectively. Additional
ly, an increasing number of positive markers per specimen appeared to
correlate with larger primary tumor size (p < 0.01) and decreased pred
icted 5-year survival (r = 0.950, p < 0.002). Conclusions: Multimarker
RT-PCR analysis appears to be a readily available and highly sensitiv
e method for the detection of axillary lymph node micrometastases. Lon
gterm followup of RT-PCR positive patients will be required to determi
ne its clinical relevance. If validated as a predictor of disease recu
rrence, this method would provide a powerful complement to routine his
topathologic analysis of axillary lymph nodes. (J Am Coil Surg 1998;18
7:9-16. (C) 1998 by the American College of Surgeons).